Randomized phase II study comparing docetaxel plus cisplatin , docetaxel plus carboplatin , and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma : a Japanese Gynecologic Oncology Group study ( JGOG 2041 )